Chuannan Fan
Leiden, ZH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Author Correction: MicroRNA-33b inhibits breast cancer metastasis by targeting HMGA2, SALL4 and Twist1.
Journal: Scientific reports
Published: September 01, 2025
circTGFBR2(3-6) acts as an assembly platform for RNA-binding protein IGF2BP3 and TGFBR1 mRNA to enhance breast cancer cell plasticity.
Journal: Cell death and differentiation
Published: April 18, 2025
Deciphering the regulatory landscape of enhancer RNAs in health and disease.
Journal: Signal transduction and targeted therapy
Published: March 13, 2025
SMAD3 and p300 complex scaffolding by long non-coding RNA LIMD1-AS1 promotes TGF-β-induced breast cancer cell plasticity.
Journal: Nucleic acids research
Published: February 20, 2025
Identification of a SNAI1 enhancer RNA that drives cancer cell plasticity.
Journal: Nature communications
Published: September 27, 2024
The lncRNA LETS1 promotes TGF-β-induced EMT and cancer cell migration by transcriptionally activating a TβR1-stabilizing mechanism.
Journal: Science signaling
Published: June 20, 2023
Periostin-TGF-β feedforward loop contributes to tumour-stroma crosstalk in liver metastatic outgrowth of colorectal cancer.
Journal: British journal of cancer
Published: February 24, 2023
LncRNA LITATS1 suppresses TGF-β-induced EMT and cancer cell plasticity by potentiating TβRI degradation.
Journal: The EMBO journal
Published: October 13, 2022
Visualizing Dynamic Changes During TGF-β-Induced Epithelial to Mesenchymal Transition.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: March 29, 2022
OVOL1 inhibits breast cancer cell invasion by enhancing the degradation of TGF-β type I receptor.
Journal: Signal transduction and targeted therapy
Published: May 20, 2021
MicroRNA-873 inhibits colorectal cancer metastasis by targeting ELK1 and STRN4.
Journal: Oncotarget
Published: July 03, 2017
miR-411-5p inhibits proliferation and metastasis of breast cancer cell via targeting GRB2.
Journal: Biochemical and biophysical research communications
Published: May 27, 2016
Last Updated: 09/26/2026